Aspirin increases the risk of bowel cancer

As recommended by the US Preventive Health Working Group, people with moderate risk of bowel cancer should not use aspirin or pain relievers such as ibuprofen to prevent this disease, as it can cause risk of bleeding and other complications. This recommendation includes people with family history of bowel cancer.

The agency said if using more than 300 milligrams a day of non-steroidal aspirin or anti-inflammatory drugs, such as iburofen and naproxen, with brands such as Motrin, Advil and Aleve, there is a high risk of stroke, flow. intestinal blood or kidney failure.

Be careful with aspirin if you are at risk of colon cancer.
(Photo: gesundheit-themenguide)

Although there is evidence that aspirin is low, less than 100 milligrams, it may reduce the risk of heart disease, but not reduce the rate of bowel cancer.

Bowel cancer is the third most common cancer in adults, and the second leading cause of cancer death in the United States, killing about 56,000 people annually. On average, there are about 150,000 more cases per year. The majority of people with diseases over the age of 50 and 20% have relatives with this disease. Black people have the highest incidence.

Previous studies have shown that a daily dose of aspirin for children can prevent pre-cancerous tumors that can become bowel cancer. But a new study suggests that low-dose aspirin has no effect on cancer prevention. Dr. Raymond DuBois, director of the Vanderbilt-Ingram Cancer Research Center in Tennessee, said the organization's recommendation is grounded. 'For everyone, the risk of gastrointestinal bleeding and intestinal bleeding due to aspirin use or cardiovascular side effects from the use of other similar drugs may be more important than the use of these drugs to prevent disease. bowel cancer. ', he said.

Huyen Trinh